evofloxacin vs piperacillin/sulbactam and sultamicillin in patients with bacterial cholangitis: A double-blind, randomised study
Completed
- Conditions
- Bacterial cholangitisInfections and Infestations
- Registration Number
- ISRCTN90588401
- Lead Sponsor
- Technical University Munich (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
1. Clinical signs of bacterial cholangitis
2. Elevated cholestase parameters
3. Elevated infection parameters
4. Age 18-90 years
Exclusion Criteria
1. Potential other cause of infection
2. Pregnancy
3. Psychiatric disease
4. Penicillin incompatibillity
5. Fluorochinolon incompatibillity
6. Leucopenia
7. Immunosuppressive medication
8. AIDS
9. Liver cirrhosis
10. Microbiological resistance against study medication
11. Biliary pancreatitis
12. Antibiotic pre-treatment within 48 hour before study inclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method